# New Strategy Study of Functional Cure of Chronic Hepatitis B

> **NCT02605252** · NA · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 120 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Peginterferon alfa-2b

## Key facts

- **NCT ID:** NCT02605252
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2017-09
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605252, "New Strategy Study of Functional Cure of Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02605252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*